10x Genomics
TXG
TXG
272 hedge funds and large institutions have $5.6B invested in 10x Genomics in 2023 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 98 increasing their positions, 79 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
24% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 79
8.6% more ownership
Funds ownership: 87.54% → 96.14% (+8.6%)
7% more funds holding
Funds holding: 254 → 272 (+18)
Holders
272
Holding in Top 10
8
Calls
$22.7M
Puts
$7.04M
Top Buyers
| 1 | +$224M | |
| 2 | +$58.6M | |
| 3 | +$38.8M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$31.6M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$31.6M |
Top Sellers
| 1 | -$47.6M | |
| 2 | -$23.6M | |
| 3 | -$22.1M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$20.5M |
| 5 |
SIM
SRS Investment Management
New York
|
-$20.4M |